West Pharmaceutical(WST) - 2024 Q2 - Quarterly Results

West Announces Second-Quarter 2024 Results - Conference Call Scheduled for 9 a.m. EDT Today - Second-Quarter 2024 Summary (comparisons to prior-year period) • Net sales of $702.1 million declined 6.9%; organic net sales declined 5.9%. • Reported-diluted EPS of $1.51, compared to $2.06 in the same period last year. • Adjusted-diluted EPS of $1.52, compared to $2.11 in the same period last year. • The Company is updating full-year 2024 net sales guidance to a range of $2.870 billion to $2.900 billion, compare ...